1175-1184
Review
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
Tsukasa Seya and Misako Matsumoto
1185-1194
Original Article
Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells
Takashi Mine, Satoko Matsueda, Yufeng Li, Hiroshi Tokumitsu and Hui Gao, et al.
1195-1206
Original Article
Open AccessDefucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
Asahi Ito, Takashi Ishida, Hiroki Yano, Atsushi Inagaki and Susumu Suzuki, et al.
1207-1218
Original Article
TGF-alpha as a candidate tumor antigen for renal cell carcinomas
Sandy Pelletier, Simon Tanguay, Stephen Lee, Lakshman Gunaratnam and Nathalie Arbour, et al.
1219-1228
Original Article
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
Robbert G. van der Most, Andrew J. Currie, Sathish Mahendran, Amy Prosser and Anna Darabi, et al.
1229-1244
Original Article
A cell-based high-throughput screen to identify synergistic TRAIL sensitizers
Nancy Lynn Booth, Thomas J. Sayers, Alan D. Brooks, Cheryl L. Thomas and Kristen Jacobsen, et al.
1245-1255
Original Article
Open AccessA possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth
Tomoe Higuchi, Masumi Shimizu, Atsuko Owaki, Megumi Takahashi and Eiji Shinya, et al.
1257-1264
Original Article
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
Terry J. Fry, Jessica L. Shand, Matthew Milliron, Sarah K. Tasian and Crystal L. Mackall
1265-1273
Original Article
Open AccessImmunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients
Valeska Hofmeister-Mueller, Claudia S. Vetter-Kauczok, Ramona Ullrich, Katharina Meder and Eugene Lukanidin, et al.
1275-1285
Original Article
Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis
Cai Zhang, Yiping Wang, Zhixia Zhou, Jian Zhang and Zhigang Tian
1287-1295
Original Article
Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains
Judith A. M. Marx, Ansgar J. Röhrborn, Bernd U. Koelsch, Christine Fischer and Thomas Herrmann, et al.
1297-1306
Original Article
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
Anna Maria Di Giacomo, Riccardo Danielli, Massimo Guidoboni, Luana Calabrò and Dora Carlucci, et al.
1307-1317
Original Article
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential
Mizue Terai, Yutaka Tamura, Vitali Alexeev, Eiko Ohtsuka and David Berd, et al.
1319-1328
Original Article
Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor
Ping Gao, Xiaolei Sun, Xing Chen, John Subjeck and Xiang-Yang Wang
1329-1336
Original Article
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines
Adam S. Giermasz, Julie A. Urban, Yutaro Nakamura, Payal Watchmaker and Rachel L. Cumberland, et al.
1337-1349
Original Article
Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF
Jennifer D. Lewis, Laura A. Sullivan, Jennifer A. Byrne, Werner de Riese and Robert K. Bright
1351-1353
Letter to the Editors
Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma
Ilyssa O. Gordon, Takisha Wade, Kevin Chin, Jerome Dickstein and Thomas F. Gajewski